Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nevada Rx PSE bill dies

This article was originally published in The Tan Sheet

Executive Summary

Nevada state legislators May 22 rejected a proposal to require pseudoephedrine-containing products to be sold only by prescription. The bill, AB 150, did not receive the necessary two-thirds majority to pass. The Consumer Healthcare Products Association lobbied against the bill after its introduction (1"The Tan Sheet" Feb. 26, 2007, In Brief). Currently, Oklahoma and Oregon each have a state law requring prescription-only access to pseudoephedrine products (2"The Tan Sheet" April 12, 2004, p. 4 and 3"The Tan Sheet" Aug. 22, 2005, p. 5)...

You may also be interested in...



Nevada PSE bill

State lawmakers Feb. 22 introduced A.B. 150 to limit the diversion of pseudoephedrine-containing OTC medicines to methamphetamine production by requiring prescriptions for the products, along with those made with ephedrine and phenylpropanolamine. The Consumer Healthcare Products Association strongly opposes the bill and will express its concerns in Nevada the week of Feb. 26. The bill is modeled after a 2005 Oregon law (1"The Tan Sheet" Aug. 22, 2005, p. 5). The Bush administration has said it will monitor the effectiveness of behind-the counter provisions of the federal Combat Meth Act as well as stricter state strategies (2"The Tan Sheet" June 12, 2006, p. 6)...

Oregon Pseudoephedrine Law Requires Prescription Status By July 2006

Oregon's State Board of Pharmacy is required to make all adult pseudoephedrine products prescription-only under a law signed by Gov. Kulongoski Aug. 16

Pseudoephedrine Tablets Go Behind The Counter In Oklahoma

Legislation restricting the sale of pseudoephedrine tablets to licensed pharmacies was signed into law in Oklahoma on April 7 and is being considered by other states looking to adopt similar measures

Topics

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel